BioSpace News Archive

Drug Development

Eleven Biotherapeutics Completes Enrollment In Pivotal Phase III Study Of Isunakinra (EBI-005) In Patients With Allergic Conjunctivitis

October 15, 2015
·
6 min read
Business

Ovid Announces Appointment Of Dr. Anna Kazanchyan To Senior Vice President, Business Development

October 15, 2015
·
3 min read
Business

Osiris Therapeutics, Inc. Announces Third Quarter 2015 Financial Results Conference Call

October 15, 2015
·
3 min read
Lone Star Bio

Opexa Therapeutics Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

October 15, 2015
·
3 min read
Drug Development

REPLICor Inc. Presents Updated Mechanistic Data And Pre-Clinical Interferon-Free Combination Treatment Data In HBV And HBV / HDV Co-Infection

October 15, 2015
·
1 min read
Business

Arcadia Biosciences Announces Date Of Third-Quarter 2015 Financial Results And Business Highlights Conference Call

October 15, 2015
·
1 min read
Business

22nd Century Group, Inc. Announces New Cannabis Research Collaboration With Anandia Laboratories

October 15, 2015
·
5 min read
Business

Great Basin Scientific Reports 143 Revenue-Generating Customers To End Third Quarter

October 15, 2015
·
3 min read
Drug Development

Cerulean Pharma Inc. Announces Completion Of Enrollment Of Randomized Phase II Trial Of CRLX101 In Combination With Avastin In Relapsed Renal Cell Carcinoma

October 15, 2015
·
5 min read
Deals

Cerecor Inc. Announces Pricing Of Initial Public Offering

October 15, 2015
·
2 min read